Introduction
Non-random chromosomal abnormalities and recurrent translocations are observed in a variety of hematolymphoid malignancies. Historically, these have defined specific subgroups of leukemias and lymphomas, including t (9;22) in CML, t (8;14) in Burkitt's lymphoma, t(14;18) in follicular center cell lymphomas and t(ll; 14) in mantle cell lymphoma. The number of disease-specific translocations in malignant tumors is growing and contributes to diagnostic accuracy, carries prognostic significance, unifies histologic criteria and finally, by identifying genomic breakpoints of biologic significance, directs the search for the molecular pathogenesis of the specific disease entity.
Mucosa-associated lymphoid tissue lymphomas (MALT) represent a well defined clinicopathologic entity characterized by an indolent clinical course, frequent multicentric and extranodal involvement and putative origin from the acquired epithelial and mucosal lymphoid tissue [1, 2] . Histologically these lymphomas represent a clonal proliferation of centrocyte-like cells with the formation of lymphoepithelial lesions, follicular colonization and a background of reactive lymphoid follicles with or without plasma cell differentiation [3] . The cell of origin of MALT lymphomas is still disputed, however, a marginal cell derivation of these tumors has been proposed by the International Lymphoma Study Group in the recently published Revised EuropeanAmerican Classification of Lymphoid Neoplasms (REAL) [4] .
Despite well recognized clinical and pathological features, MALT lymphomas have seldom been characterized from a cytogenetic and molecular perspective. To date, the karyotypic features of 28 cytogenetically abnormal MALT lymphomas have been published. This low number reflects the fact that few diagnostic centers utilize cytogenetics in the diagnostic work up of nonHodgkin's lymphomas. Even in centers where cytogenetic studies are regularly part of the investigation of lymph node biopsies, it is often neglected when extranodal biopsies are submitted. Despite these difficulties, some MALT karyotypic data have been reported. Published cases reveal trisomy 3 as the most common abnormality, present in approximately 56%-85% of the cases as detected by the application of standard or interphase cytogenetics [5, 6] . In the period between 1985-1997 we have collected cytogenetic data on eight cases of MALT lymphoma, two of which carry the reciprocal translocation t(ll;18)(q21;q21). Another case of orbital MALT lymphoma carrying the same translocation had been refered to us in consultation from University of Nebraska Medical Center and is also included in our cohort. A review of the literature detected an additional six cases sharing similar clinical, histopathological and cytogenetic data. Detailed analysis of these nine cases and a comprehensive review of the literature are presented in this report.
Materials and methods
The British Columbia Cancer Agency is the primary referral centre for patients diagnosed with hematolymphoid malignancies in the province of British Columbia, Canada. A total of 116 cases of MALT lymphoma were diagnosed at BCCA between 1988 and 1997. Eleven cases of pathologically confirmed MALT lymphomas were submitted for cytogenetic analysis at the time of the initial evaluation Eight of 11 cases yielded successful cultures and the presence of a clonal karyotype was identified using standard cytogenetic methodology. In addition, a single case of orbital MALT lymphoma with a clonal karyotype has been obtained through our consultative practice from University of Nebraska Medical Center. These nine cases of MALT lymphoma with a clonal karyotype are the subject of this report.
Histology
Diagnostic material was fixed in buffered formalin or B5 fixative, sectioned at three microns, routinely processed and stained with hematoxylin and eosin. Histologjc subclassification as low grade lymphoma was based on the Working Formulation [7] . Diagnostic criteria for MALT lymphomas published in the Revised European-American Classification of Lymphoid Neoplasms were observed in each case [4] . Clonality was established based on either immunohistochemical evidence of light chain restriction (case #1, #9), flow cytometry (case #6) or molecular analysis of immunoglobulin heavy chain gene (IgH) rearrangements utilizing polymerase chain reaction (PCR) methodology (cases #2, #3, #5, #7). In the remaining cases (#4, #8), the presence of an abnormal karyotype was considered sufficient evidence of clonality.
Cytogeoetic analysis
Nodal or extranodal tissue obtained at the time of primary diagnosis was mechanically disaggregated with a scalpel blade to obtain a single cell suspension. The cells were cultured at 37 °C for 24 hours in RPMI 1640 medium supplemented with 10% fetal calf senim, glutamine and antibiotics. Metaphases were G-banded by the GTG method. Karyotypes were described according to 1995 ISCN guidelines [8] .
Molecular analysis
High molecular weight DNA extracted from the diagnostic material on cases #1-5, 7 and 9 was obtained for PCR. Analysis of the IgH VDJ and bcl-2 regions was performed using a modification of published method [9] , utilizing the consensus VJ, mbr and mcr primers, respectively.
Literature review
Cytogenetic data on low grade lymphomas published in the English literature were reviewed. Careful attention was given to the Results section of articles to include only cases meeting clinical, histologic and immunophenotypic criteria for the diagnosis of MALT lymphoma [4] , Excluded were cytogenetically studied cases of CLL/SLL, mantle cell lymphoma, primary splenic lymphomas and nodal monocytoid/marginal lymphomas. Although these latter two entities may represent part of the histologic spectrum of marginal zone B-cell lymphoproliferative disorders which may include MALT lymphomas, we chose to restrict the literature review to CD5 negative low grade lymphoma cases involving mucosal and/or epithelial sites.
Results
Tissue on 12 biopsies with the diagnosis of MALT lymphoma was submitted for cytogenetic analysis. Two cases were excluded from the study due to failure to obtain adequate chromosome preparations and one case yielded normal metaphases only, leaving a total of nine cases with an abnormal karyotype. One of these cases has been previously published in a single case report (case #3) [10] .
A summary of the clinical data is provided in Table 1 . The female : male ratio was 2 :1 with a median age of 64 46,XX,t(ll;18)(q21,q21) [4] years (range 43-76 years). All cases had extranodal involvement at presentation, including: stomach (#1, 3, 8) , small intestine (#4), parotid gland (#6, 7), orbit (#2, 9) and lacrimal gland (#5). Three cases (#3, 4, 5, 9) had multicentric organ involvement at diagnosis. None of the patients suffered from autoimmune disorders. Formalin or B5 fixed, paraffin embedded and H & E stained diagnostic biopsies on all eight cases were reviewed to confirm the pathologic diagnosis of MALT lymphoma. Histologically, seven cases showed exclusively low grade MALT lymphoma and one case (#1) showed transformation to a high grade MALT with an underlying low grade component still evident.
The karyotypic data are presented in Table 2 . Cytogenetic analysis revealed the presence of an abnormal karyotype in each of the nine cases. All cases except case #9 also revealed constitutional metaphases with a normal karyotype. Two cases harboured two apparently unrelated abnormal clones (#3, 7). Two cases (#1 and #5) contained a hypotetraploid chromosome complement with numerical and structural aberrations. A recurrent reciprocal translocation t(ll;18)(q21;q21) was observed in three cases (#3, 8, 9) and the t(14;18)(q32;q21) that is characteristically seen in follicular lymphoma, although the bcl-2 gene was found to be in a germline configuration using PCR for both mbr and mcr breakpoints. Molecular analysis of the IgH gene revealed the presence of a monoclonal B cell population in cases #2, 3, 5 and 6. The amplification of control DNA failed in case #8, which precluded further analysis. The survey of the cytogenetic data on MALT lymphomas extracted from the relevant English literature yielded 28 reported cases with a clonal karyotype. These are combined with the nine cases representing our cytogenetic experience for MALT lymphomas at BCCA (Table 3) . A summary of the clinicopathologic, immunophenotypic and cytogenetic data on MALT lymphomas with a t(ll;18)(q21;q21) are presented in Table 4 .
Discussion
Standard cytogenetic analysis constitutes part of the initial diagnostic investigation of suspected malignant lymphoma in many institutions and has contributed to the discovery of unique and previously unreported aberrations in lymphoid neoplasia [5, 6, 12, 13] . A review of the relevant literature revealed only 28 cases of low grade B-cell lymphomas fulfilling the criteria for MALT lymphoma for which aberrant clonal karyotypic data was provided [10, [14] [15] [16] [17] [18] [19] .
In this study, we report the cytogenetic findings in nine successfully cultured cases of MALT lymphoma seen at our institution. We have identified three cases of recurrent t(ll;18)(q21;q21), one of which had been previously published as a single case report [10] . Six additional cases with t(ll;18) were extracted from the literature [14] [15] [16] 18] . All nine cases share similar cyto- [7] /46,XY [15] 46,XX,t(ll,18)(q21;q21) [4] 46,XY,t(ll;18)(q21;q21) [13] /46,XY [5] 46,XX,t(ll;18)(q21;q21) [27] /46,XX [12] 46,XX,t(TT,T8) (q21 ;q21) [22] 46,XY,t(ll;18)(q21;q21) [27] /47,XY,+3 [3] 46,XY,t(ll;18)(q21;q21) [7] 46,XX,t(ll;18)(q21;q21)[ll]/46,XX [9] genetic, histopathologic and clinical characteristics (Tables 3 and 4) , suggesting that the t(ll;18)(q21;q21) may identify the location of an oncogene important in the pathogenesis of MALT lymphoma in humans. All cases affected middle age to elderly predominantly female patients (range 50-73 years) and presented at extranodal sites (stomach, lung, bowel, lacrimal gland, orbit). Interestingly, four of the nine cases had multicentric organ involvement at the time of diagnosis. This finding is in contrast to most MALT lymphoma cases, which typically present as localized (stage 1) disease. The results suggest that the t(ll;18) may be associated with a tendency to early dissemination and involvement of other mucosal sites. Cytogenetic analysis of additional cases will be of benefit in further exploring this relationship. Histologically, the three cases reported here, as well as the case published by Leroux [16] and Kubonishi et al. [18] with similar cytogenetic abnormalities were histologically classified as extranodal B-cell lymphomas of MALT type. The remaining four cases, reported by Griffin et al. [15] and Levine et al. [14] , were diagnosed as small lymphocytic lymphoma, however the details of their histopathologic appearance are not provided in the respective reports. Based on the immunohistochemical features, particularly the lack of CD5 expression, the clinical data and extranodal involvement suggests that these cases may indeed represent extranodal MALT lymphomas. It is interesting to see an exclusive lambda light chain restriction in all six MALT cases harbouring t(ll;18) in which immunohistochemical data are available (Table 4 ).
The single case of primary MALT lymphoma of the lung documented by Kubonishi et al [18] revealed a three way translocation involving chromosomes 11, 12 and 18. The ISCN description of the translocation indicates breakpoints at Ilql3, 12ql3 and 18ql2, however our review of the published karyotype reveals that the der(ll) is very similar to that found in our cases of t(ll;18) and suggests that breakpoints at Ilq21 and 18q21 may be involved. Such breakpoint interpretation would indicate that this case may represent a three way translocation variant and align this case as an additional example of t(ll;18)(q21;q21) in MALT lymphoma. It may also suggest that the der(ll) t(ll;18) may be the critical recombination. In light of the published breakpoints being different, this potentially informative case is not included in Table 4 .
The translocation t(ll;18)(q21;q21) in all reported cases (including the three-way translocation reported by Kubonoshi [18] ) is almost always present as a single clonal aberration with the exception of case #3 reported here. In contrast, trisomy 3, identified as the most frequent cytogenetic abnormality associated with MALT lymphomas and present in nine of the 28 clones of the previously published cases, is accompanied by other numerical and structural karyotypic alterations in all but one case [5, [19] [20] [21] .
The underlying molecular mechanism by which t(ll;18)(q21;q21) may be related to the pathogenesis of MALT lymphoma remains speculative at this stage. A number of genes have been located to chromosome 18q21, particularly the bcl-2 oncogene which is deregulated by t(14;18)(q32;q21.3) in up to 90% of follicular lymphomas [22] and 20%-30% of diffuse large B-cell non-Hodgkin's lymphomas (NHL) [23] . Interestingly, one of our histologically low grade MALT cases (#2) demonstrated a stemline with t(14;18)(q32;q21) accompanied by trisomy 3. Review of the histologic material confirmed this case as a MALT lymphoma. PCR analysis revealed the bcl-2 gene to be present in germline configuration. The association of trisomy 3 with t(14;18)(q32;q21) in MALT lymphoma has not been previously reported and its significance remains uncertain. Although the involvement of bcl-2 in t(ll;18)(q21;q21) is suggested by the breakpoint at 18q21, Southern analysis using mbr and mcr probes has not confirmed the presence of a bcl-2 rearrangement in cases harbouring a t(l 1; 18) [10] , although pulsed field gel electrophoresis (PFGE) has not been reported. Interestingly, some follicular lymphomas are associated with a variant translocation involving a transcriptional unit located 10 Kb upstream of the bcl-2 locus termed FVT1 [24] . This unit may potentially be altered by the t(ll;18) in MALT lymphomas, resulting in upregulated expression of bcl-2 protein and the inhibition of programmed cell death. It is of interest that no FTV1 rearrangements were detected by pulse field gel electrophoresis in the MALT case described by Leroux et al. Alternatively, the breakpoint in the t(ll;18) in MALT lymphomas may be located at some distance from and not implicate the bcl-2 gene.
A number of candidate genes other than bcl-2 which may be dysregulated as a result of t(ll;18)(q2ql;q21) are located near 18q21. The YES1 gene at 18q21.3 is asso-ciated with tyrosine-specific protein kinase activity and shows a high degree of homology to the src gene product of the Rous sarcoma virus, but is not rearranged in the t(14;18) of follicular lymphoma [25] . Also mapped to 18q21.3 are the tumor suppressor gene DCC [26] [27] [28] , the SMAD gene (also known as DPC4) which acts as a tumour suppressor gene and is deleted in up to 90% of human pancreatic carcinomas [29] and the MADH2 which has been shown to code for a signaling protein involved in the transduction of growth inhibitory signals from TGF-beta [30] . The speculated suppressive influence of MADH2 on neoplasia may be altered or lost during translocation. SSAV1 [31] and MASPIN [32] are also located within band 18q21. Genomic mapping in this chromosomal region if far from complete, however, and the 18q21 region may contain a family of apoptosis related genes which have evolved during the development of chromosome 18 as is seen for other families of genes such as the cytokine genes on 5q. Dysregulated expression of such a gene could have a effect similar to that ofbcl-2 in follicular lymphoma.
Fewer potential candidate genes have been mapped to chromosome Ilq21, although chromosome llq translocations and deletions are not uncommon in hematolymphoid malignancies including mantle cell lymphoma, chronic lymphocytic leukemia and acute leukemias [33] . The candidate genes at Ilq21 include CLG1 and matrix metalloproteinase-7 (MMP-7) encoding for MMP-8 and MMP-7 respectively, both of which are implicated in normal, pathologic and cancer associated tissue remodeling [34] . More detailed characterization of the breakpoints involved in the t(ll;18)(q21;q21) could implicate one of these candidate genes or result in the identification of a novel gene involved in the development of MALT and other human lymphomas.
In summary, MALT lymphomas are cytogenetically heterogeneous often displaying one or more distinct clones with structural rearrangements, trisomies, monosomies, tetraploidy and a pattern of clonal evolution similar to that of other types of NHL. We have previously suggested that the t(ll;18) may be a recurrent translocation associated with MALT lymphoma [10] and this appears to be substantiated by our more recent data and other published cases. The t(ll;18)(q21;q21) represents the most common recurrent structural rearrangement associated with MALT lymphomas, accounting for 33% of our cases and a similar percentage of other published cases. This information should initiate a search for the etiologic genes disrupted by this rearrangement and involved in the pathogenesis of this subset of MALT lymphoma.
